Answers are grounded in this paper and cite their sources.
Review discusses multitarget drug design for neurodegenerative conditions, indicating promising neuroprotective potential.
The combination of several pharmacophores in one molecule may not only result in the mere addition of the useful properties of each component, but may also give rise to new types of biological activity. The examples of the appearance of new properties in such multipharmacophore compounds, not inherent in the reference agents, discussed in our review, may be considered a prospective approach for creating a novel generation of neuroprotective agents.
No takes yet. Share an insight, caveat, or question.
Shevtsova et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: